United States

BioClinica Revenues Flat in ‘09

Thursday, February 11, 2010

BioClinica reported its fourth quarter and full-year 2009 earnings earlier this week. Service revenues for the quarter were almost flat from the fourth quarter 2008 at $14.9 million. Income from continuing operations was $943,000, or $0.06 per fully diluted share, compared with income of $1.7 million for the same period 2008.

[Read More]

PPD Profits Fall Short in 2009

Tuesday, February 9, 2010

PPD’s full-year income from operations fell 32% in 2009, the contract research organization (CRO) reported last night. Revenues for the year were also down from $1.55 billion in 2008 to $1.42 billion.

[Read More]

etrials Cuts Costs—and Losses in Q1

Wednesday, May 13, 2009

eClinical vendor etrials Worldwide cut its net loss for the first quarter 2009 in half from the same period 2008 by reducing operating expenses, the company said. Net loss for Q1 was $960,000, compared with $2 million in Q1 2008—and $5.5 million in the fourth quarter 2008.

[Read More]

Kendle Faces Questions about Pricing Pressures

Monday, May 11, 2009

After warning investors two weeks ago that first quarter 2009 revenues would be significantly lower than expected, Cincinnati-based contract research organization (CRO) Kendle released its first quarter earnings late last week—reporting a 78% drop in profit compared with the same period last year.

[Read More]